Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder
- PMID: 17912251
- DOI: 10.1038/sj.npp.1301575
Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder
Abstract
Bipolar disorder (BPD) is characterized by recurrent episodes of disturbed affect including mania and depression as well as changes in psychovegetative function, cognitive performance, and general health. A growing body of data suggests that BPD arises from abnormalities in synaptic and neuronal plasticity cascades, leading to aberrant information processing in critical synapses and circuits. Thus, these illnesses can best be conceptualized as genetically influenced disorders of synapses and circuits rather than simply as deficits or excesses in individual neurotransmitters. In addition, commonly used mood-stabilizing drugs that are effective in treating BPD have been shown to target intracellular signaling pathways that control synaptic plasticity and cellular resilience. In this article we draw on clinical, preclinical, neuroimaging, and post-mortem data to discuss the neurobiology of BPD within a conceptual framework while highlighting the role of neuroplasticity in the pathophysiology and treatment of this disorder.
Similar articles
-
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.Acta Psychiatr Scand. 2012 Nov;126(5):332-41. doi: 10.1111/j.1600-0447.2012.01889.x. Epub 2012 Jun 8. Acta Psychiatr Scand. 2012. PMID: 22676371 Free PMC article. Review.
-
Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.Curr Drug Metab. 2018;19(8):663-673. doi: 10.2174/1389200219666171227203737. Curr Drug Metab. 2018. PMID: 29283064 Review.
-
The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder.Neurosci Biobehav Rev. 2022 Nov;142:104906. doi: 10.1016/j.neubiorev.2022.104906. Epub 2022 Oct 4. Neurosci Biobehav Rev. 2022. PMID: 36206993 Review.
-
Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity.Brain Res. 2009 Oct 13;1293:76-84. doi: 10.1016/j.brainres.2009.06.103. Epub 2009 Jul 10. Brain Res. 2009. PMID: 19595676 Free PMC article. Review.
-
Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder.Neuropsychopharmacology. 2008 Oct;33(11):2551-65. doi: 10.1038/sj.npp.1301671. Epub 2008 Jan 30. Neuropsychopharmacology. 2008. PMID: 18235426 Review.
Cited by
-
Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder.Front Behav Neurosci. 2021 Feb 26;15:609487. doi: 10.3389/fnbeh.2021.609487. eCollection 2021. Front Behav Neurosci. 2021. PMID: 33732117 Free PMC article. Review.
-
A bidirectional competitive interaction between circHomer1 and Homer1b within the orbitofrontal cortex regulates reversal learning.Cell Rep. 2022 Jan 18;38(3):110282. doi: 10.1016/j.celrep.2021.110282. Cell Rep. 2022. PMID: 35045295 Free PMC article.
-
Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder.Bipolar Disord. 2014 Sep;16(6):617-23. doi: 10.1111/bdi.12204. Epub 2014 Apr 10. Bipolar Disord. 2014. PMID: 24716786 Free PMC article.
-
Epigenetic principles and mechanisms underlying nervous system functions in health and disease.Prog Neurobiol. 2008 Dec 11;86(4):305-41. doi: 10.1016/j.pneurobio.2008.10.001. Epub 2008 Oct 17. Prog Neurobiol. 2008. PMID: 18940229 Free PMC article. Review.
-
Changes in the medial prefrontal cortex metabolites after 6 months of medication therapy for patients with bipolar disorder: A 1H-MRS study.CNS Neurosci Ther. 2024 Sep;30(9):e70048. doi: 10.1111/cns.70048. CNS Neurosci Ther. 2024. PMID: 39300492 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical